insights_auto
Why is PEB up 7.14%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.22
arrow_upward
+7.14%(+0.015) 1D
Nov 19, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.21
High
A$0.22
Low
A$0.21
Mkt. cap
335.55M
Avg. vol.
56.67K
Volume
22.00K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.21
High
A$0.22
Low
A$0.21
Mkt. cap
335.55M
Avg. vol.
56.67K
Volume
22.00K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Top Movers: Gainers and Losers Today
FXStreet
·
17 minutes ago
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Investing.com
·
10 minutes ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
Traders Union
·
1 hour ago
Caleb Franzen: S&P 500 performance and AI stocks diverged under Powell and Warsh
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com